We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+15.82%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$624M
AUM Growth
+$32.5M
Cap. Flow
-$51.3M
Cap. Flow %
-8.21%
Top 10 Hldgs %
57.01%
Holding
39
New
5
Increased
17
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$30.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$15.9M
3
BIIB icon
Biogen
BIIB
+$13.8M
4
DGX icon
Quest Diagnostics
DGX
+$8.03M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.66M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$41.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$24.1M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$15.9M
4
LLY icon
Eli Lilly
LLY
+$15.8M
5
TAK icon
Takeda Pharmaceutical
TAK
+$15M

Sector Composition

Rank Sector Weight
1 Healthcare 99.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$62M 9.93%
965,433
-421,289
-30% -$24.1M
ABT icon
2
Abbott
ABT
$175B
$49.2M 7.87%
565,997
+28,737
+5% +$2.41M
BSX icon
3
Boston Scientific
BSX
$65.4B
$46.9M 7.51%
1,037,023
-71,313
-6% -$2.98M
MRK icon
4
Merck
MRK
$315B
$32.3M 5.17%
+371,825
New +$30.5M
BIIB icon
5
Biogen
BIIB
$30.4B
$30.3M 4.86%
102,219
+49,793
+95% +$13.8M
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
$30M 4.8%
387,580
-80,678
-17% -$5.7M
RVTY icon
7
Revvity
RVTY
$12.3B
$29.9M 4.79%
308,099
+7,901
+3% +$705K
GILD icon
8
Gilead Sciences
GILD
$167B
$27M 4.33%
415,605
-59,451
-13% -$3.87M
INCY icon
9
Incyte
INCY
$23.4B
$24.7M 3.95%
282,542
-63,351
-18% -$5.41M
A icon
10
Agilent Technologies
A
$37.1B
$23.8M 3.8%
278,427
+18,134
+7% +$1.43M
ELV icon
11
Elevance Health
ELV
$80.9B
$23.1M 3.7%
76,508
+1,901
+3% +$523K
BRKR icon
12
Bruker
BRKR
$8.86B
$17.4M 2.79%
341,750
+33,746
+11% +$1.61M
JNJ icon
13
Johnson & Johnson
JNJ
$609B
$17.1M 2.74%
+117,229
New +$15.9M
BIO icon
14
Bio-Rad Laboratories Class A
BIO
$8.15B
$16.6M 2.66%
44,870
-1,498
-3% -$528K
HUM icon
15
Humana
HUM
$48B
$16.6M 2.66%
45,261
+1,262
+3% +$400K
QGEN icon
16
Qiagen
QGEN
$8.49B
$14.7M 2.35%
409,391
-47,615
-10% -$1.77M
PRGO icon
17
Perrigo
PRGO
$1.48B
$14.1M 2.26%
272,644
+14,800
+6% +$774K
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
$13.6M 2.19%
126,164
+36,200
+40% +$3.87M
UTHR icon
19
United Therapeutics
UTHR
$22.7B
$13.3M 2.12%
150,615
+2,468
+2% +$217K
IONS icon
20
Ionis Pharmaceuticals
IONS
$8.99B
$13.1M 2.11%
217,635
+86,121
+65% +$5.13M
ELAN icon
21
Elanco Animal Health
ELAN
$12.9B
$12.8M 2.04%
433,477
+16,435
+4% +$447K
CAH icon
22
Cardinal Health
CAH
$53.5B
$10.8M 1.72%
212,563
+15,264
+8% +$788K
REGN icon
23
Regeneron Pharmaceuticals
REGN
$70.9B
$10.7M 1.71%
28,458
-47,377
-62% -$15.9M
PDCO
24
DELISTED
Patterson Companies, Inc.
PDCO
$9.78M 1.57%
477,355
+8,100
+2% +$153K
UHS icon
25
Universal Health Services
UHS
$9.15B
$9.45M 1.51%
65,864
+1,122
+2% +$160K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2019 Portfolio in Review

As of Q4 2019, Sector Gamma AS held 39 positions worth $624M, up 5.5% from $592M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sector Gamma AS withdrew a net $51.3M in Q4 2019, closing 2 positions and reducing 15 holdings. Its most notable exit was Baxter International, an estimated $41.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Merck worth $32.3M.

  • Sector Gamma AS's largest Q4 2019 buy was Merck: 371,825 shares worth $32.3M.
  • Sector Gamma AS added most to Biogen in Q4 2019, an estimated $13.8M increase.
  • Sector Gamma AS's biggest Q4 2019 reduction was Bristol-Myers Squibb, cutting an estimated $24.1M.
  • Sector Gamma AS fully exited Baxter International in Q4 2019, selling an estimated $41.3M.
  • Sector Gamma AS's ten largest holdings make up 57% of its $624M portfolio in Q4 2019.
  • Sector Gamma AS opened 5 new positions and closed 2 in Q4 2019.
  • Sector Gamma AS's portfolio value rose 5.5% quarter-over-quarter to $624M.

Based on Sector Gamma AS's 13F filing for Q4 2019, filed 12 Feb 2020.